Flu Vaccine Market, By Type (Split Virus Vaccines, Sub-unit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

The flu vaccine market accounted for US$ 6.21 billion in 2020 and is estimated to be US$ 12.59 billion by 2030 and is anticipated to register a CAGR of 7.4%.

Flu is a short term for “influenza,” the official name of this infectious or viral illness. It is caused by influenza viruses and it infect nose, throat and even lungs. It is communicable viruses, these viruses spread when people with flu cough, sneeze or talk, through droplets its spread. But it’s a temporary illness that gets resolved itself as the immune system fights it off. The symptoms usually appear from in two to four days, and this virus last for four to seven days. Flu vaccine also known as Flu shots, it’s been given with the help of needle, usually in the arm, but there a nasal spray available in market. Using this type of vaccines may have some of the side effects include: runny nose, wheezing, headache, vomiting, muscle aches, fever, sore throat and cough. Not everybody suffers from the side effects, it is totally depending on the person’s immune activity. There are two types flu shots available: inactivated influenza vaccine and live attenuated influenza vaccines.

Growing number of patients of influenza disease across the globe had an impact on the growth of the flu vaccine market. As well as the government implement different strategies to boost the uptake of flu vaccine in the countries. In recent times, the increasing awareness among the people with respect to infectious diseases had led to timely vaccination in the emerging nations. Different countries had various strategies to run immunization programs.

However, longer timeline for the production of vaccines might be the root cause that hampers the growth of the market.  Novel vaccine production is long process it usually takes 10-14 years to launch a proper vaccine for any the disease. Longer legalization of vaccines is another factor that restraints the growth of flu vaccine market.

The flu vaccine market is segmented based on type, application, and region.

On the basis of type, the flu vaccine market is segmented into split virus vaccines, subunit vaccines and others. On the basis of application, the target market is segmented into for children and for adults and children over 3 years.

Regional Insights:

The flu vaccine market accounted for US$ 6.21 billion in 2020 and is estimated to be US$ 12.59 billion by 2030 and is anticipated to register a CAGR of 7.4%. On region the flu vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the influenza market. This is due to the rapid launch of effective products, coupled with technologically advanced vaccine manufacturing system across the region. Moreover, the regulating bodies implementing vaccination centers and hospitals in this region fuel the flu vaccine market. Asia-Pacific is expected to showcase inclination in the upcoming years, due to rising population in this region boost vaccination market

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global flu vaccine market report based on type, application, and region.

Flu Vaccine Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • U.S.
  • Canada

The key players operating in the flu vaccine market includes CSL Ltd, GSK LLC, Sanofi Pasteur, Mylan N.V., AstraZeneca PLC, Pfizer Inc., and Johnson & Johnson Company. The merging and acquisitions of the pharma companies lead to better aid of the diseases or viruses.

• CSL Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• GSK LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Sanofi Pasteur
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Mylan N.V.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Astra Zeneca PLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Johnson and Johnson Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for Flu Vaccine Market Strategies
     • Key Questions this Study will Answer

     • By Type (Split Virus Vaccines, Subunit Vaccines, and Others)

       By Application (For Children and For Adults and Children over 3 years),

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Flu Vaccine Market Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• CSL Itd, GSK LLc, Sanofi Pasteur, Mylan N.V., AstraZeneca PLC, Pfizer Inc., and Johnson & Johnson Company.

1. The Last Word
   • Future Impact
   • About Us
   • Contact